Brian Stover, MD

Pediatric Hematologist/Oncologist (Child Cancer Specialist)

Active clinical trials

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other…

Investigators: William Slayton, Brian Stover
Status: Accepting Candidates
Ages: 3 Years - 29 Years
Sexes: All

A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment o

This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after…

Investigators: William Slayton, Brian Stover
Status: Accepting Candidates
Ages: N/A - 22 Years
Sexes: All

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Ne

Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy using…

Investigators: William Slayton, Brian Stover
Status: Accepting Candidates
Ages: N/A - 21 Years
Sexes: All